| SYK |
Report |
Revenue |
BEAT |
pred ~$6.70B vs. cons $6.58B |
MEDIUM |
| SYK |
Report |
Organic sales growth |
BEAT |
pred ~10.2% vs. cons 9.0% |
MEDIUM |
| SYK |
Report |
Adjusted EPS |
BEAT |
pred ~$3.57 vs. cons $3.49 |
MEDIUM |
| SYK |
Guide |
FY2026 adjusted EPS guidance |
UNCHANGED |
guide ~$15.00 vs. cons $15.02 (FY2026) |
HIGH |
| SYK |
Guide |
FY2026 organic sales growth guidance |
UNCHANGED |
guide ~8.8% vs. cons 8.8% (FY2026) |
HIGH |
| SYK |
Guide |
2H organic-growth recovery commentary |
BETTER |
guide ~10.8% vs. cons 10.5% (2H2026) |
MEDIUM |
| SYK |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.8% |
— |
MEDIUM |
| SYK |
Return |
5-day cumulative residual |
+4.0% (FOLLOW-THROUGH) |
A revenue-and-EPS beat alongside confirmation of roughly 10.8% 2H organic growth should support upward revisions to quarterly estimates and reduce the perceived risk that the cyber disruption caused durable demand or execution damage. |
MEDIUM |